Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122715) titled 'Evaluation of the Effect and Analysis of Influencing Factors of Hepatitis B Vaccine Combined with Hepatitis B Immunoglobulin in Blocking Mother-to-Child Transmission of Hepatitis B in Jilin Province' on April 16.
Study Type: Observational study
Study Design:
Cross-sectional
Primary Sponsor: Jilin Provincial Center for Disease Control and Prevention(Jilin Provincial Academy of Preventive Medicine)
Condition:
Hepatitis B
Intervention:
Single Immunotherapy Group:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2025-09-18
Target Sample Size: Single Immunotherapy Group:125;Co...